Skip to content

ESG vs LSG: Short-term Nutritional Outcomes

Endoscopic Sleeve Gastroplasty in Comparison With Laparoscopic Sleeve Gastrectomy in Terms of Short-Term Nutritional Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04264364
Enrollment
57
Registered
2020-02-11
Start date
2019-06-16
Completion date
2019-11-25
Last updated
2020-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endoscopic Sleeve Gastroplasty, Laparoscopic Sleeve Gastrectomy, Obesity

Brief summary

To assess endoscopic sleeve gastroplasty in comparison to laparoscopic sleeve gastrectomy before and 3 months after the procedure in terms of multiple nutrition-related factors, quality of life, weight and other related parameters.

Detailed description

This will be a short-term prospective cohort study, single-center study (NewYou clinical center - Riyadh). A total of 15 endoscopic sleeve gastroplasty patients will be matched with 15 laparoscopic sleeve gastrectomy patients by age, gender and BMI. Total sample size is 30 patients. Sample size was selected based on literature, considering the sample will be surgical patients and based on booked patients in the clinic. A multidisciplinary team will provide post-procedure care (including post-surgery diet stages protocol given by the center).

Interventions

PROCEDURELaparoscopic sleeve gastrectomy

Bariatric surgical intervention

Endoscopic bariatric procedure

Sponsors

King Saud Medical City
CollaboratorOTHER_GOV
King Saud University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Adult (≥ 18 years old) * Willingness and ability to participate * Males and females * Non-pregnant

Exclusion criteria

* Children (\<18 years old) * Pregnant

Design outcomes

Primary

MeasureTime frameDescription
Weight Loss3 monthsWeight Loss in kilograms (baseline weight in kilogram - follow-up weight in kilogram)
Percentage of total weight loss (%TWL)3 months%TWL = \[(baseline weight in kilogram - weight at 3 months in kilogram) ÷ baseline weight in kilogram\]
Percentage of excess weight loss (%EWL)3 months%EWL = \[percentage of weight lost compared with excess weight, which is defined as baseline weight in kilogram - the weight corresponding to a BMI of 25 kg/m\^2 in kilogram\])
Waist Circumference3 monthsWaist Circumference in centimeters
body fat percentage change3 monthschange in body fat percentage between baseline and follow-up visits as calculated by a calibrated bioelectrical impedance device
fat mass change3 monthschange in fat mass in kilograms between baseline and follow-up visits as calculated by a calibrated bioelectrical impedance device
fat mass index change3 monthschange in fat mass index in kg/m\^2 between baseline and follow-up visits as calculated by a calibrated bioelectrical impedance device
fat free mass change3 monthschange in fat free mass in kilograms between baseline and follow-up visits as calculated by a calibrated bioelectrical impedance device
fat free mass index change3 monthschange in fat free mass index in kg/m\^2 between baseline and follow-up visits as calculated by a calibrated bioelectrical impedance device
skeletal muscle mass change3 monthschange in skeletal muscle mass in kilograms between baseline and follow-up visits as calculated by a calibrated bioelectrical impedance device
Dietary habits3 monthsAssessment of dietary habits using the How Healthy Is Your Diet questionnaire, developed by the British Heart Foundation 2012 The score is from 0 minimum to 29. Higher score correlates with better dietary habits.
24-hour dietary recall3 monthsAssessment of nutritional intake with 24-hour dietary recall form
3-day dietary record3 monthsAssessment of nutritional intake with 3-day dietary record
Change in quality of life after procedure3 monthsMoorehead-Ardelt Quality of Life Questionnaire II scoring using Moorehead-Ardelt Quality of Life Questionnaire II Self Esteem and Activity Levels SCORING KEY minimum score is -3 and maximum score is 3 a higher score means a better outcome.
Cholesterol Biochemical assessment (laboratory assessment)3 monthsCholesterol in milligrams per deciliter (\< 200 Desirable)
Alanine Aminotransferase Biochemical assessment (laboratory assessment)3 monthsAlanine Aminotransferase in units per liter (up to 33)
Gamma glutamyl transferase Biochemical assessment (laboratory assessment)3 monthsGamma glutamyl transferase in units per liter (\< 40)
sodium Biochemical assessment (laboratory assessment)3 monthssodium in millimoles/liter (136-145)
platelets Biochemical assessment (laboratory assessment)3 monthsplatelets in cmm (150.0-450.0)
MCH Biochemical assessment (laboratory assessment)3 monthsMCH in picograms per cell (25.00-32.00)
potassium Biochemical assessment (laboratory assessment)3 monthspotassium in millimoles/liter (3.5-5.1)
MCV Biochemical assessment (laboratory assessment)3 monthsMCV in femtoliters per cell (76.00-97.00)
MCHC Biochemical assessment (laboratory assessment)3 monthsMCHC in grams per deciliter (31.80-35.40)
Chloride Biochemical assessment (laboratory assessment)3 monthsChloride in millimoles/liter (97-111)
creatinine Biochemical assessment (laboratory assessment)3 monthscreatinine in mg/dL (44-80)
WBC Biochemical assessment (laboratory assessment)3 monthsWBC in × 10\^9/L (4.00-11.00)
RBC Biochemical assessment (laboratory assessment)3 monthsRBC in million mcL (3.80-5.80)
HCT Biochemical assessment (laboratory assessment)3 monthsHCT in % (36.00-46.00)
serum glucose Biochemical assessment (laboratory assessment)3 monthsserum glucose in mg/dL (70-150)
serum TSH Biochemical assessment (laboratory assessment)3 monthsserum TSH in milli-international units per liter (0.38-5.33)
hemoglobin Biochemical assessment (laboratory assessment)3 monthshemoglobin in grams per deciliter (12.00-16.00)
Eosinophils Biochemical assessment (laboratory assessment)3 monthsEosinophils in cells per microliter (0.00-6.00)
monocytes Biochemical assessment (laboratory assessment)3 monthsmonocytes in percent (0.00-13.70)
INR plasma ratio Biochemical assessment (laboratory assessment)3 monthsINR plasma ratio (no units)
Basophils Biochemical assessment (laboratory assessment)3 monthsBasophils in basophils per microliter (0.00-1.00)
MPV Biochemical assessment (laboratory assessment)3 monthsMPV in fl (7.20-11.10)
RDW Biochemical assessment (laboratory assessment)3 monthsRDW in % (12.40-16.20)
lymphocytes Biochemical assessment (laboratory assessment)3 monthslymphocytes in % (15.00-50.00)
neutrophils Biochemical assessment (laboratory assessment)3 monthsneutrophils in cells/µL (40.00-75.00)

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026